Want to see AU:BGT full AI Analyst Report?
Total Valuation
Bio-Gene Technology Ltd. has a market cap or net worth of AU$7.45M. The enterprise value is AU$4.07.
Market CapAU$7.45M
Enterprise ValueAU$4.07
Share Statistics
Bio-Gene Technology Ltd. has 438,061,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding438,061,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bio-Gene Technology Ltd.’s return on equity (ROE) is -1.11 and return on invested capital (ROIC) is -135.48%.
Return on Equity (ROE)-1.11
Return on Assets (ROA)-0.89
Return on Invested Capital (ROIC)-135.48%
Return on Capital Employed (ROCE)-1.63
Revenue Per Employee0.00
Profits Per Employee-466.16K
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bio-Gene Technology Ltd. is ―. Bio-Gene Technology Ltd.’s PEG ratio is 0.07.
PE Ratio―
PS Ratio0.00
PB Ratio2.81
Price to Fair Value2.81
Price to FCF0.00
Price to Operating Cash Flow-2.77
PEG Ratio0.07
Income Statement
In the last 12 months, Bio-Gene Technology Ltd. had revenue of 0.00 and earned -2.33M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit-42.00K
Operating Income-3.41M
Pretax Income-2.80M
Net Income-2.33M
EBITDA-3.36M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.94M and capital expenditures -4.00, giving a free cash flow of -1.94M billion.
Operating Cash Flow-1.94M
Free Cash Flow-1.94M
Free Cash Flow per Share>-0.01
Dividends & Yields
Bio-Gene Technology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.39
52-Week Price Change-52.78%
50-Day Moving Average0.02
200-Day Moving Average0.03
Relative Strength Index (RSI)30.31
Average Volume (3m)236.23K
Important Dates
Bio-Gene Technology Ltd. upcoming earnings date is Mar 3, 2027, TBA (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateMar 3, 2027
Ex-Dividend Date―
Financial Position
Bio-Gene Technology Ltd. as a current ratio of 4.78, with Debt / Equity ratio of 0.00%
Current Ratio4.78
Quick Ratio4.78
Debt to Market Cap0.00
Net Debt to EBITDA0.58
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bio-Gene Technology Ltd. has paid -469.50K in taxes.
Income Tax-469.50K
Effective Tax Rate0.17
Enterprise Valuation
Bio-Gene Technology Ltd. EV to EBITDA ratio is -1.17, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA-1.17
EV to Free Cash Flow0.00
EV to Operating Cash Flow-2.03
Balance Sheet
Bio-Gene Technology Ltd. has AU$1.94M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$1.94M billion.
Cash & Marketable SecuritiesAU$1.94M
Total DebtAU$0.00
Net CashAU$1.94M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bio-Gene Technology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast38.52%